| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-13 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-12 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-12 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.31 | 7e-11 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-11 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.38 | 2e-10 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-10 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.26 | 8e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.33 | 1e-07 |